Browse by Poster Presenter

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Browse by Poster Presenter

Type here to filter the list

C
Cabada-Aguirre, Paulina

University of Illinois Chicago
(W1130-04-26) Peonidin-3-O-Glucoside and Resveratrol Reduce Human hFOB Osteoblast Apoptosis and Alter the Expression of Genes Associated with Apoptosis, Differentiation and Osteoclastogenesis
Paulina Cabada-Aguirre
Favorite
Cabalar, Pedro

University of A Coruna
(M1130-02-12) Machine Learning Predicts Pharmaceutical Inkjet Printing Outcomes
Pedro Cabalar
Favorite
(T0930-02-08) Accelerating Development of FDM 3D Printed Medicines with Machine Learning
Pedro Cabalar
Favorite
Cacace, Janice

CoreRx
(M1130-12-83) A Data Based Approach to Selection of Bioavailability Enhancement Strategy Using New Simultaneous Dissolution-Flow Through Permeability for Formulation Development
Janice Cacace
Favorite
Cafiero, Claudio

Aptuit (Verona) Srl, an Evotec Company
(M1130-11-70) A DoE Approach to Study the Influence of TSWG Process Parameters on the Characteristics of Granules and Tablets
Claudio Cafiero
Favorite
Caisse, Philippe

Gattefosse SAS
(T0930-03-15) In Vivo Confirmation of the Permeation Enhancement Capacity of Labrafac™ MC60
Philippe Caisse
Favorite
Cai, Xiao-Yan

Accurant Biotech
(W1030-06-36) Novel Technical Breakthrough: qPCR with Reported LLOQ of 8 Copies / mg DNA in a 20 µL Reaction
Xiao-Yan Cai
Favorite
Cai, Yingjun

International Flavors and Fragrances Inc.
(M1230-02-09) Comparison of Controlled-Release Performance between Carrageenan and Several Other Hydrophilic Polymers
Yingjun Cai
Favorite
(T1130-11-70) Application of Colloidal MCC and Xanthan in Challenging Suspension Formulation
Yingjun Cai
Favorite
(T1230-02-08) Application of Ac-Di-Sol® SD-711 in Orally Disintegrating Tables (ODTs): Performance Comparison of Croscarmellose Sodium and Crospovidone
Yingjun Cai
Favorite
Calderon, Chris

Ursa Analytics
(M1530-09-57) Combining Machine Learning and Backgrounded Membrane Imaging: A Case Study in Comparing and Classifying Different Types of Biopharmaceutically Relevant Particles
Chris Calderon
Favorite
Callahan, Jordan

Aprecia Pharmaceuticals Company
(T1130-09-62) Manufacture of Low-Dose Rapidly Disintegrating Dosages Using 3DP Binder Jetting
Jordan Callahan
Favorite
Campbell, Christopher

Meso Scale Discovery
(M1230-06-37) Development of a Sensitive and Specific Phospho-Tau 217 [Tau (pT217)] Biomarker Assay for Alzheimer’s Disease in Plasma and Serum
Christopher Campbell
Favorite
Campbell, Gregory

NDA Partners, a ProPharma Group Company
(M1430-10-65) Comparing a t-Distribution Based Bayesian Approach with the Two One-Sided t-Test (TOST) for Bioequivalence Studies in Real-World Datasets
Gregory Campbell
Favorite
Campbell, Joseph

Prolytix - Essex Junction, VT
(M1430-09-58) Improvements to PS80 Detection in Drug Product Formulations: A Mixed Mode High-Performance Liquid Chromatography Method for the Quantification and Improvement in the Detection of Polysorbates
Joseph Campbell
Favorite
Campbell, Sam

CritiTech, Inc
(T1130-12-78) Particle Engineering of Large Surface Area, Low Bulk Density, High Drug Load Particles of Poorly Water-Soluble Drugs for Depot Delivery at the Site of Disease
Sam Campbell
Favorite
Campi, Francesca

Evotec
(M0930-11-71) Characterization of Compression Behavior of Co-processed Excipient for Production of Orally Dispersible Tablets and of Their Blends with Active Ingredient
Francesca Campi
Favorite
(T0930-03-20) Impact of Tooling Size on the Heckel Profile and Derived Compressibility Parameters
Francesca Campi
Favorite
(W0930-11-76) A Study to Assess the Gastro-Resistance and Dissolution Rate of Enteric Coated Not-Banded Gelatin and HPMC Capsules
Francesca Campi
Favorite
Campos-Alvarez, Andre

FabRx Ltd.
(W0930-08-55) Distributed Manufacturing of 3D Printed Pharmaceuticals: A Case Study
Andre Campos-Alvarez
Favorite
Canal, Clinton

Mercer University
(M1330-04-27) Activating 5-HT 1A Receptors as a Treatment for Fragile X Syndrome: A Preclinical Study in Fmr1 Knockout Mice
Clinton Canal
Favorite
Canham, Spencer

Husson University
(M1130-06-36) Characterization of Blueberry-Derived Exosomes: New Insights into a Potential Nanomedicine
Spencer Canham
Favorite
Cao, Weiqun

WuXi AppTec DMPK
(M1330-10-63) Effect of pH on Metabolite Profiling and Identification of GalNAc Conjugated siRNA in In Vitro Metabolic System
Weiqun Cao
Favorite
(T1230-10-69) Metabolite Identification of Nucleoside Analog Prodrugs in Biological Matrix by Derivatization Coupled with Radio-Detector and Mass Spectrometry
Weiqun Cao
Favorite
Capella, Peter

US Food and Drug Administration
(W1130-02-08) Colestipol Hydrochloride Tablets: Challenges of Formulating a Complex Active Pharmaceutical Ingredient and Product Quality Considerations
Peter Capella
Favorite
Caplain, Henri

DNDi
(M1430-10-68) Physiologically-Based Pharmacokinetic (PBPK) Modeling of Oral Absorption of 5-flucytosine to Support Development of a Sustained-Release Formulation for Treatment of Cryptococcal Meningoencephalitis
Henri Caplain
Favorite
Caraballo, Isidoro

Universidad de Sevilla
(T1230-08-54) Development of 3D-Printed Bicompartmental Tablets by Dual Fused Deposition Modelling (FDM) for Site-Specific Colon Drug Delivery
Isidoro Caraballo
Favorite
(W0930-08-49) Study and Characterization of Polyurethane Mixtures to be Employed in Direct Powder Extrusion Using Expert Systems
Isidoro Caraballo
Favorite
Carangelo, Sebastiano

Aptuit (Verona) Srl, an Evotec Company
(M0930-11-71) Characterization of Compression Behavior of Co-processed Excipient for Production of Orally Dispersible Tablets and of Their Blends with Active Ingredient
Sebastiano Carangelo
Favorite
Carbol, Jason

Dow Development Labs, LLC
(M1030-02-11) Exploring the Use of Silicone-Based Microemulsions for Formulating Aesthetically Pleasing Topical Pharmaceuticals: Enhancing Patient Compliance and Product Aesthetics
Jason Carbol
Favorite
(T1030-01-03) Critical Material Attributes (CMA) of Excipients in Topical Formulations: The Pitfalls of Switching between Compendial Raw Materials without a Full Analysis of all Critical Quality Attributes (CQA)
Jason Carbol
Favorite
Cardot, Jean-Michel

SAS Borbo
(M1030-08-51) Automated In Vitro Population Bioequivalence for Inhaled Products to Meet the FDA Guidance on Budesonide Using Phoenix® WinNonlin®
Jean-Michel Cardot
Favorite
Carlert, Sara

AstraZeneca
(W0930-09-57) New Insights into Non-classical Crystallization of Pharmaceutical Solids: Chemically-Specific Coherent Raman Imaging of Liquid-Liquid Phase Separation
Sara Carlert
Favorite
Carou-Senra, Paola

Universidade de Santiago de Compostela
(M1130-02-12) Machine Learning Predicts Pharmaceutical Inkjet Printing Outcomes
Paola Carou-Senra
Favorite
(W1130-12-79) Personalisation of Data Matrix Encoded Hydrocortisone Orodispersible Films Using Inkjet Printing
Paola Carou-Senra
Favorite
Carpenter, David

Evecxia Therapeutics, Inc.
(M0930-11-73) Formulation Optimization of EVX-101, a Novel Gastro-Retentive Prolonged-Release 5-HTP/Low-Dose Carbidopa Tablet
David Carpenter
Favorite
Carpenter, Maggie

Thermo Fisher Scientific
(T1130-08-55) Monolayer Tablet Compression Process Optimization Using a Response Surface Method Design of Experiments
Maggie Carpenter
Favorite
Carr, Amanda

Pfizer Inc.
(W1030-12-82) Navigating Titanium Dioxide Free Coating Systems: Evaluating the Risk and Understanding the Alternatives
Amanda Carr
Favorite
Carr, Andrew

Charles River Laboratories
(T1030-09-60) Investigation into How Solvent Selection Affects the Metastable Zone of Paracetamol During a Thermally Controlled Recrystallisation
Andrew Carr
Favorite
Carrasco-Roja, Natalia

University of Florida
(M1130-11-75) Radiation-Induced Tumor Penetration of Mesoporous Silica Nanoparticles for Enhanced Treatment of Ovarian Cancer Peritoneal Metastasis
Natalia Carrasco-Roja
Favorite
Carr, Geoffrey

Patheon, Part of Thermo Fisher Scientific
(M1130-08-55) Effects of SDS Quality and Dissolution Medium Warm-Up Time on Dissolution Release of MRTX849 IR Tablets, 200 mg
Geoffrey Carr
Favorite
Carrigy, Nicholas

AstraZeneca
(M1530-03-16) Robust Rugose Lipid Microparticles for Respiratory Delivery of Biologics
Nicholas Carrigy
Favorite
Carrilho, Emanuel

Universidade de Sao Paulo
(M1130-01-02) Development of Therapeutic Immunoliposome to Deliver Recombinant Human Enzyme for the Treatment of Pompe Disease
Emanuel Carrilho
Favorite
Carter, Carina

Bioagilytix
(M1430-06-36) Qualification of a Neurology 2-Plex B (Nf-L, GFAP) Quanterix Simoa® Assay Using a Novel Approach
Carina Carter
Favorite
Carver, Holly

Indiana University
(M1030-04-28) Comparative Cell Viability Study for Paclitaxel Loaded PLGA-PEG Nanoparticles in Established U-87 and Patient Derived Primary GBM10, GBM39, GBM43 and GBM75 Glioblastoma Cells
Holly Carver
Favorite
Casas, Marta

University of Seville
(W0930-08-49) Study and Characterization of Polyurethane Mixtures to be Employed in Direct Powder Extrusion Using Expert Systems
Marta Casas
Favorite
Casettari, Luca

University of Urbino Carlo Bo
(T1130-08-53) Microfluidic-Assisted Preparation of ARV 825 and Osimertinib Loaded Liposomal Formulation as a Potential System for Colorectal Cancer Therapy
Luca Casettari
Favorite
Cassier, Hadi

Mirati Therapeutics
(M1030-09-61) Characterization of Stress Induced Amorphous Phase Formation during Tableting Detected by Solid-State NMR – Implications on Stability and Formulation Selection
Hadi Cassier
Favorite
Castaneda Ruiz, Angel

University of Bonn
(W1030-11-70) Biodegradable Cationic Nanoparticles Prepared with Methylmethacrylate Copolymers Derivatives for Immune Activation and Cancer Immunotherapy
Angel Castaneda Ruiz
Favorite
Castano, Jesus

Ambry Genetics
(M1030-06-36) Stabilization of Human Cells for RNA Extraction Using Capillary-Mediated Vitrification Process
Jesus Castano
Favorite
Castejon, Ana

Nova Southeastern University
(M1530-05-30) Metformin Induced-Oxidative Stress Modulates LNCaP Cellular Redox Status and Suppressed Cell Growth
Ana Castejon
Favorite
Castro, Maria

University of Michigan
(T1230-03-15) Controlled Release of Monoclonal Antibodies from Long-Acting PLGA-Coated Implants
Maria Castro
Favorite
Cave, Joseph

Houston Methodist Research Institute
(W1130-10-66) Multiscale Modeling-Identified Synergistic Combinations of Anti-microRNA-155 and Standard-of-Care Drugs for Improved Outcomes in Non-small Cell Lung Cancer
Joseph Cave
Favorite
Cech, Thorsten

BASF SE Pharma Solutions
(M1530-12-80) A New and Sustainable Twin Screw Wet Granulation Method Making Subsequent Drying Obsolete
Thorsten Cech
Favorite
Cerea, Matteo

Universita degli Studi di Milano
(T1230-01-03) Novel Expandable Platform for Retentive Drug Delivery Systems
Matteo Cerea
Favorite
Cerri, Daniel Giuliano

Universidade de Sao Paulo
(M1130-01-02) Development of Therapeutic Immunoliposome to Deliver Recombinant Human Enzyme for the Treatment of Pompe Disease
Daniel Giuliano Cerri
Favorite
Cesarano, Lewis

Coperion K-Tron
(T1030-08-53) Impact of Microcrystalline Cellulose Grade and Vibrational Feeding Assistance on Loss-in-Weight Continuous Feeding
Lewis Cesarano
Favorite
(W1130-08-51) Impact of Microcrystalline Cellulose Particle Size Grade on Loss-in-Weight Continuous Feeding
Lewis Cesarano
Favorite
Ceulemans, Jens

Janssen
(M1330-01-04) Characterizing the Drug Gastrointestinal Transfer Process after Disintegration of Solid Dose Units in the Fed State
Jens Ceulemans
Favorite
(W1130-01-02) Itraconazole Concentrations in the Colloidal Aqueous Phase of Contents of Upper Small Intestine after the Standard High-Calorie High-Fat Meal and Their Relevance to Itraconazole Plasma Levels
Jens Ceulemans
Favorite
Chackerian, Bryce

University of New Mexico
(M0930-02-08) A Novel Immunization Strategy against Malaria Using Microneedles and Virus-Like Particles Vaccine
Bryce Chackerian
Favorite
Chadha, Aastha

Mirati Therapeutics
(T0930-02-14) Improvement of Mechanical Properties of MRTX0902 by Crystalline Form Selection and Particle Engineering
Aastha Chadha
Favorite
Chae Yeong, Hong

Yonsei University
(M1030-03-17) Enhance Transport of Adenosine Integrated in Lipid Nanoparticles Crossing Reconstructed Human Epidermis
Hong Chae Yeong
Favorite
Chakravarty, Paroma

Genentech, Inc.
(T1430-11-70) Assessing the Impact of Dry Particle Coating with Nano-Silica on Compaction Properties of Cohesive Active Pharmaceutical Ingredients
Paroma Chakravarty
Favorite
(W1030-01-01) Investigating the Relationship between Material Attributes of API and the Extent of Powder Property Enhancement via Dry Particle Coating with Nano-Silica
Paroma Chakravarty
Favorite
Cha, Kwang-Ho

Dong-A ST
(W0930-11-75) Discovery and Development of Memantine Transdermal Patch
Kwang-Ho Cha
Favorite
(W1130-11-74) Pre-clinical and Clinical Evaluation of a Weekly Donepezil Transdermal Patch
Kwang-Ho Cha
Favorite
Chalamuri, Shanmuka

Tulex Pharmaceuticals Inc.
(M1030-03-21) Exploring the Potential of Polyvinyl Acetate Dispersion and PVP-90 to Prevent Alcohol-Induced Dose Dumping in Modified Release Formulations
Shanmuka Chalamuri
Favorite
Chalmers, David

Quotient Sciences
(T1530-03-21) A First-in-Human Assessment for TQS-168, Including Safety, Tolerability, Pharmacokinetics, Formulation Selection, and Food Effect in Healthy Volunteers
David Chalmers
Favorite
Chambliss, Walter

University of Mississippi
(W1130-01-03) The Development of Extended-Release and Mucoadhesive Buccal Films of Adipic Acid by Hot-Melt Extrusion for Long-Term Relief of Xerostomia
Walter Chambliss
Favorite
Chamcha, Venkateswarlu

Merck & Co., Inc.
(M1130-09-56) Development of an Industry Ready Cell-Based Potency Method for an Oncolytic Virus Immunotherapy
Venkateswarlu Chamcha
Favorite
Chandler, Cole

Creighton University
(M1230-11-76) Topical Ocular Administration of Hydrogen Sulfide Donor: Assessment of Permeability through Isolated Bovine Cornea Ex Vivo
Cole Chandler
Favorite
(T1330-11-73) Investigating and Optimizing the Influence of Process Parameters on Development of Polymeric Microparticles: A Quality-by-Design Approach
Cole Chandler
Favorite
Chandra, Divya

Merck Research Laboratories
(M0930-08-49) Novel Strategies for Process-Related Impurity Clearance during Biologics Manufacturing
Divya Chandra
Favorite
Chandrahas, Vish

B2S Life Sciences
(M1030-06-38) Immunocapture LC-MS/MS Assay for the Biomarker, Troponin Fast (TNNI2) Using a Specific Antibody
Vish Chandrahas
Favorite
Chandrasekaran, Prabagaran

Teva Pharmaceuticals, Inc.
(M1130-02-11) Extended Release Abuse Deterrent Formulation of an Opioid Analgesic
Prabagaran Chandrasekaran
Favorite
Chan, Edwin

Chinese University of Hong Kong
(M1330-02-13) Preparation and Optimization of Piperine Nanoparticles for Its Intranasal Delivery
Edwin Chan
Favorite
Chang, Hao-Han (Ricky)

University of Toronto
(W1230-01-04) Development of a Novel Polymeric Composite Film and Elucidation of Its New Alcohol-Resistant Mechanisms for the Prevention of Alcohol-Induced Dose Dumping
Hao-Han (Ricky) Chang
Favorite
Chang, Irene

Merck & Co., Inc.
(M1330-08-49) CryoTEM Characterization of Vaccine Materials in Development
Irene Chang
Favorite
Chan, Warren

Merck Research Laboratories
(M0930-08-49) Novel Strategies for Process-Related Impurity Clearance during Biologics Manufacturing
Warren Chan
Favorite
Chao, Ruilin

Sun Yat-Sen University
(M1430-01-04) Shear-Induced Crystallization of Amorphous Indomethacin
Ruilin Chao
Favorite
Chappell, John

Gyros Protein Technologies
(T1030-06-37) Strategies for Measuring Oligonucleotides Using a Fully Automated Microfluidic Immunoassay System
John Chappell
Favorite
(W1230-06-38) Measuring Free IgE in Low-Affinity Interaction with Omalizumab Using an Automated Microfluidic Immunoassay to Support Pharmacokinetics and Pharmacodynamics Studies
John Chappell
Favorite
Charbe, Nitin

University of Florida
(M1230-10-64) PBPK Modeling Coupled with Biorelevant Dissolution to Forecast the Oral Performance of Amorphous Solid Dispersion Formulations
Nitin Charbe
Favorite
(M1530-10-68) Assessing the In Vitro Performance of Solid Dosage Forms Over-Encapsulated with the ID-Cap System for Improved Compliance
Nitin Charbe
Favorite
Charbe, Nitin Bharat

University of Florida
(W1130-10-65) Development and Validation of a Physiologically Based Pharmacokinetic Model of Tofacitinib in Mice to Predict Dosing in Higher Animal Species
Nitin Bharat Charbe
Favorite
Charnock, Colin

Oslo Metropolitan University
(M1430-01-03) Fusogenic Liposomes as an Approach to Enhance the Efficacy of Antimicrobials
Colin Charnock
Favorite
Chase, Liam

University of Pennsylvania
(T1230-03-16) Conjugation Chemistry of Antibody-Liposome Conjugates Affects Performance via Complement Activation and Mechanisms Thereof
Liam Chase
Favorite
Chattopadhyay, Somesh

US Food and Drug Administration
(M1430-10-65) Comparing a t-Distribution Based Bayesian Approach with the Two One-Sided t-Test (TOST) for Bioequivalence Studies in Real-World Datasets
Somesh Chattopadhyay
Favorite
Chaturvedi, Nagendra

University of Nebraska Medical Center
(M1230-10-63) Characterization of Preclinical In Vitro and In Vivo Pharmacokinetics Properties for JNJ-64619178, a New Therapeutic for the Treatment of Medulloblastoma
Nagendra Chaturvedi
Favorite
(M1430-10-66) Assessment of In Vitro and In Vivo Pre-clinical Pharmacokinetics of EPZ015666; a Novel Small Molecule for Medulloblastoma Treatment
Nagendra Chaturvedi
Favorite
Chaudhari, Dasharath

National Institute of Pharmaceutical Education and Research
(M1230-01-06) Screening of Synergistic Combination of Ferroptosis-Inducing Drugs and Development of Targeted PLGA Nanoparticles for Improved Anti-Cancer Therapy
Dasharath Chaudhari
Favorite
Chaudhuri, Bodhisattwa

University of Connecticut
(T1330-08-52) Development of a Discrete Element Method (DEM) Model to Study the Impact of Process Parameters and Material Attributes on Continuous Twin Screw Wet Granulation Process
Bodhisattwa Chaudhuri
Favorite
(T1530-09-60) Impact of Vacuum Drum Filling Parameters on Dry Powder Inhaler Performance
Bodhisattwa Chaudhuri
Favorite
(W0930-09-60) Mitigation of Tribocharging in Pharmaceutical Powders Using Surface Modified V-Blenders
Bodhisattwa Chaudhuri
Favorite
(T1430-09-56) Using Experimentally Validated ML Modeling to Predict the Thawing Time of Biologics During Large Scale Freeze-Thawing Cycles
Bodhisattwa Chaudhuri
Favorite
Chau, Gilda

MD Anderson Cancer Institute
(T1230-04-22) The Paracrine Action of Mutant p53 in Breast Cancer
Gilda Chau
Favorite
Chauhan, Anuj

Colorado School of Mines
(M1330-03-21) Developing Degradable Microparticles for the Delivery of Inactivated H1N1 Virus and NKT Cell Agonist for Single Dose Vaccination
Anuj Chauhan
Favorite
Chauhan, Neha

Secant Group
(T1430-06-38) Content Uniformity, Drug Quantification and Cross-Reactivity Analysis of Protein Loaded PGSU Implants Using Raman Spectroscopy and Reverse-Phase High Performance Liquid Chromatography (RP-HPLC)
Neha Chauhan
Favorite
Chaulagain, Bivek

North Dakota State University
(W1230-01-05) Brain Targeted Delivery of Cannabidiol and Brain Derived Neurotrophic Factor (BDNF) for Attenuation of Inflammation and Promotion of Neurogenesis for the Management of Alzheimer’s disease
Bivek Chaulagain
Favorite
Chavan, Devendra

United States Pharmacopeia
(M1330-09-60) Compendial Strategy to Define Composition and Quality of Polysorbates
Devendra Chavan
Favorite
Chavez-Eng, Cynthia

Merck & Co., Inc.
(W0930-10-69) Islatravir Does Not Partition to Red Blood Cells: An In Vitro Study to Support a Total Drug Assay in Dried Blood
Cynthia Chavez-Eng
Favorite
Chawdry, Suliman

Bristol-Myers Squibb Company
(M1030-12-81) Development of a Platform Coating Approach to Taste Masking Bitter Drugs in Micro-tablets for Pediatric Patients
Suliman Chawdry
Favorite
Chemmannur, Sijo

Precision NanoSystems, Inc.
(T1530-12-82) Well Characterized Lipid Nanoparticle Library Accelerates Development of Next Generation Genomic Medicines
Sijo Chemmannur
Favorite
Chenel, Marylore

Pharmetheus AB
(M1430-10-68) Physiologically-Based Pharmacokinetic (PBPK) Modeling of Oral Absorption of 5-flucytosine to Support Development of a Sustained-Release Formulation for Treatment of Cryptococcal Meningoencephalitis
Marylore Chenel
Favorite
(W0930-10-65) Bioavailability and Local Immunogenicity after Subcutaneous Administration of Therapeutic Proteins: Mechanistic Modelling within the Open Systems Pharmacology Framework
Marylore Chenel
Favorite
Chen, Y. Eugene

University of Michigan
(W1130-06-36) Understanding Synthetic High-Density Lipoprotein Remodeling Ex Vivo Using Human Serum
Y. Eugene Chen
Favorite
Chenevert Aijala, Jennett

Stoke Therapeutics, Inc.
(M1130-06-40) Development and Validation of a Sensitive Hybridization-Electrochemiluminescence (H-ECL) Method for Quantitation of STK-002, an Antisense Oligonucleotide, in Human Serum
Jennett Chenevert Aijala
Favorite
Chen, Fangfang

Boehringer Ingelheim
(T1130-06-36) Method Development of BI-X ADC Gyrolab Assay for the Determination of Anti-BI-X Antibodies
Fangfang Chen
Favorite
Chen, Genfu

WuXi AppTec Co., Ltd.
(T1530-10-69) Evidence-Based Strategies for the Characterization of New Chemical Entity (NCE) In Vitro CYP and Non-CYP Enzyme Reaction Phenotyping at the Development Stage
Genfu Chen
Favorite
Cheng, Jenny

AstraZeneca
(T1030-10-65) A Review of Immunogenicity and Its Effect on Efficacy and Safety of Biologics as Reported on the Prescribing Label to Support Strategic Assessment and Planning Labeling Communications
Jenny Cheng
Favorite
(W0930-10-66) Leveraging Nausea Exposure-Response Relationship to Optimize Titration and Dose Selection Decisions for Cotadutide
Jenny Cheng
Favorite
Cheng, Kun

University of Missouri Kansas City
(T1330-04-23) Discovery of Anti-Transforming Growth Factor β Receptor II (TGFβRII) Cyclic Peptides
Kun Cheng
Favorite
Cheng, Sau Wan

Chinese University of Hong Kong
(W1030-06-40) Gastrointestinal Digestion and Fermentation of Astragalus membranaceus Polysaccharides
Sau Wan Cheng
Favorite
Cheng, Yi-Hsien

US Food and Drug Administration
(W0930-10-67) Utilizing PBPK Absorption Modeling to Evaluate Impact of Single-Sex on Bioequivalence Evaluation of Atorvastatin Immediate Release Tablets
Yi-Hsien Cheng
Favorite
Cheng, Yi-Hsien

Kansas State University
(W1030-02-09) Development of an Artificial Intelligence-Based PBPK Model for Nanoparticles in Tumor-Bearing Mice
Yi-Hsien Cheng
Favorite
Chen, Hansong

US Food and Drug Administration
(M1430-10-64) Physiologically Based Biopharmaceutics Modeling of BCS Class I Extended-Release Drug Products: A Preliminary Exploration
Hansong Chen
Favorite
Chen, Hao

University of Tennessee Health Science Center
(M1530-01-06) Combination Therapy of BRD4/PI3K Dual Inhibitor and Novel Tubulin Inhibitor Efficiently Treats Chemo-Resistant Pancreatic Cancer
Hao Chen
Favorite
Chen, Hongyi

Fudan University
(T1130-03-17) Transcytosis Mediated Deep Tumor Penetration for Enhanced Chemotherapy and Immune Activation of Pancreatic Cancer
Hongyi Chen
Favorite
Chen, Howard

Blueprint Medicines
(M1530-11-75) Role of Citric Acid in Enhancing Drug Performance: A Double-Edged Sword?
Howard Chen
Favorite
Chen, Jiamin

Zhejiang Huahai Pharmaceutical Co, Ltd.
(M1430-08-55) Quantitative Determination of Microcrystalline Cellulose in Drug Products by Chemometrics Analysis of Raman Spectroscopy
Jiamin Chen
Favorite
Chen, Julie Y.

Horiba Instruments, Inc.
(M1130-09-58) NTA Analysis: Linear Range Evaluation for Exosomes
Julie Y. Chen
Favorite
Chen, Kang

US Food and Drug Administration
(T1430-09-62) Characterization of Intravenous Iron Supplements: Injectafer^®
Kang Chen
Favorite
Chen, Kun

BASF Corporation
(M1030-03-18) Formulation of Omeprazole Minitablets with Delayed Release: A Seal and Enteric Polymer Coating Approach
Kun Chen
Favorite
Chen, Lorenzo

Merck & Co., Inc.
(M1130-08-53) Investigation of Non-specific Adsorption of Lipid Components of the Emulsion-Based Formulations Stored in Glass Vials
Lorenzo Chen
Favorite
chen, Pengyu

Auburn University
(M1530-02-14) β-catenin Inhibition Using XAV939 Nanoparticle Promotes Immunogenic Cell Death and Suppresses Tumor Progression
Pengyu chen
Favorite
(T1330-02-12) Novel Bio-Active Peroxisomal Proliferator Activating Receptor Gamma (PPARγ) Hydrogel for Periodontitis Management
Pengyu chen
Favorite
(W1030-04-24) Diethyldithiocarbamate Copper Nanoparticle Overcomes Resistance in Cancer Therapy without Inhibiting P-glycoprotein
Pengyu chen
Favorite
Chen, Qiran

University of Florida
(W1030-02-09) Development of an Artificial Intelligence-Based PBPK Model for Nanoparticles in Tumor-Bearing Mice
Qiran Chen
Favorite
Chen, Ron

Mirati Therapeutics
(T0930-02-14) Improvement of Mechanical Properties of MRTX0902 by Crystalline Form Selection and Particle Engineering
Ron Chen
Favorite
Chen, W.

Colorcon, Inc.
(M1230-02-14) The Influence of Coating Parameters on Transparency of Semi-permeable Membrane Coating of Push-Pull Osmotic Pump Tablets
W. Chen
Favorite
Chen, Xuan

Primera Analytical Solutions
(M1430-08-50) Leachable Analysis of Ethylene Vinyl Acetate Infusion Bags by GC-FID-MS and LC-UV-MS
Xuan Chen
Favorite
Chen, Yi

WuXi AppTec (Shanghai) Co., Ltd.
(W1030-05-33) Study on the Permeability of Ophthalmic Tissues In Vitro
Yi Chen
Favorite
Chen, Yong

Nantong University
(T1430-12-82) Personalized 3D Printing Earring Tap for Treating Affections Caused by Aesthetic Perforations
Yong Chen
Favorite
Chen, Yuan

Texas Southern University
(W1030-01-03) The Design and Assessment of Sustained Release from PLGA/PEG Blend Nanoparticles for Intravenous Application
Yuan Chen
Favorite
Chen, Zhengyu

Precision NanoSystems, Inc.
(M1530-12-83) Effect of LNP Components on mRNA-Mediated Protein Expression of Lipid Nanoparticles in Different Organs
Zhengyu Chen
Favorite
(T1530-12-82) Well Characterized Lipid Nanoparticle Library Accelerates Development of Next Generation Genomic Medicines
Zhengyu Chen
Favorite
Chen, Zhenxuan

Merck & Co., Inc.
(T0930-09-58) Crystallization Kinetics of Amorphous Lactose: The Difference between α and β Anomers
Zhenxuan Chen
Favorite
Cheo, David

Mesoscale Diagnostics
(T1230-06-37) Expansion of the Human Immuno-Oncology Assay Portfolio on a Multiplexed Electrochemiluminescence Platform
David Cheo
Favorite
Cheong, Jaehyun

Chung-Ang University
(W0930-12-81) Combination Therapy for the Reversal of Multi-drug Resistant Cancer
Jaehyun Cheong
Favorite
Cheong, Jonathan

Genentech, Inc.
(W1130-10-67) Effects of Abcb1 and Abcg2 on the Brain Penetration, Biliary Disposition, and Intestinal Secretion of the PI3K Inhibitor Taselisib
Jonathan Cheong
Favorite
Cheon, Sehyeok

Korea University
(M1130-10-64) Effect of Amounts of DMSO and Incubation Time on BBB-PAMPA Permeability of Drugs with High and Low BBB Permeability
Sehyeok Cheon
Favorite
(T1530-08-51) Effect of Morphologies and Process Parameters on Aerodynamic Performance of Fluticasone Propionate in Dry Powder Inhaler
Sehyeok Cheon
Favorite
(W1230-02-12) Polymorphism and Solvatomorphism of Niclosamide-Camostat Cocrystals and Bioavailability Enhancement of Low-Solubility API via Co-Crystallization
Sehyeok Cheon
Favorite
Cheplo, Kathleen

Cytokinetics, Incorporated
(M1430-10-69) Disposition and Metabolism of the Cardiac Myosin Inhibitor Aficamten in Humans
Kathleen Cheplo
Favorite
Cherif, Achref

University of Mississippi
(M1330-03-17) Performance Evaluation of Different Diluents for the Direct Compression of Acetaminophen Tablets
Achref Cherif
Favorite
Chetty, Kieran

Ashland Inc.
(M1230-01-03) Characterization of Drug Release from a Blended Biodegradable Polymeric Film Using a Central Composite Design
Kieran Chetty
Favorite
Chhibber, Tanya

University of Utah
(T1230-11-73) Injectable Antibacterial Dressings for the Prevention of Bacterial Biofilm in Chronic Rhinosinusitis (CRS)
Tanya Chhibber
Favorite
Chhonker, Yashpal

University of Nebraska Medical Center
(M1030-10-63) In Vitro and In Vivo Pharmacokinetics of a Novel B7-H3 Inhibitor (Ni1) for the Treatment of Group 3 Medulloblastoma
Yashpal Chhonker
Favorite
(M1230-10-63) Characterization of Preclinical In Vitro and In Vivo Pharmacokinetics Properties for JNJ-64619178, a New Therapeutic for the Treatment of Medulloblastoma
Yashpal Chhonker
Favorite
(M1430-10-66) Assessment of In Vitro and In Vivo Pre-clinical Pharmacokinetics of EPZ015666; a Novel Small Molecule for Medulloblastoma Treatment
Yashpal Chhonker
Favorite
(T1430-10-65) Novel Biomarkers for Inflammatory Bowel Disease
Yashpal Chhonker
Favorite
(W1130-04-27) The Effect of MO-OH-Nap Tropolone on Osteosarcoma Cellular Metabolism
Yashpal Chhonker
Favorite
(W1230-06-39) Simultaneous LC-MS/MS Method for the Quantitation of Azithromycin, Hydroxychloroquine and its Metabolites In SARS-CoV-2(-/+) Populations Using Dried Blood Spots
Yashpal Chhonker
Favorite
Chiang, Yi-Hua

University of Florida
(M1430-10-67) Effect of Food on the Pharmacokinetics of Mitragynine in Rats
Yi-Hua Chiang
Favorite
(T0930-10-64) Pharmacokinetic Studies of 7-hydroxymitragynine, the Active Metabolite of Mitragynine, in Rats
Yi-Hua Chiang
Favorite
(T1230-10-67) Pharmacokinetic Profiles of Paynantheine and Its Diastereomer, Isopaynantheine, in Sprague-Dawley Rats
Yi-Hua Chiang
Favorite
Chilamula, Srikanth

University of Mississippi
(T1030-01-04) Solubility Enhancement of Atorvastatin Calcium Using Cyclodextrin
Srikanth Chilamula
Favorite
Chintakindi Bhasker, Mohit

Tergus Pharma, LLC
(M1330-08-52) Optimization of USP Method for Quantitation of Beta Glucan Using a High-Performance Liquid Chromatography and Adapting to a Low Strength Semisolid Dosage Form
Mohit Chintakindi Bhasker
Favorite
(M1430-08-52) Systematic Root Cause Analysis for Investigation of Contamination Peak in an Ovicidal Topical Product
Mohit Chintakindi Bhasker
Favorite
(W1030-08-50) Development of a Gel Filtration Chromatography Method for Polyglutamic Acid in a Semisolid Dosage Form
Mohit Chintakindi Bhasker
Favorite
Chinye, Chrystabel

University of Bath
(W0930-03-19) Improved Distribution of Water Insoluble Components in Soluble Thin Film Formulations
Chrystabel Chinye
Favorite
Chiruvolu, Shivkumar

Applied Materials
(M1330-03-15) Effect of Atomic Layer Coatings on the Stability of Solid Myoglobin Formulations
Shivkumar Chiruvolu
Favorite
Chitnis, Kshitij

University of Mississippi
(W0930-01-04) Fabrication and Characterization of Amlodipine Besylate Based Sub-cutaneous Implants: Fabricated with the Help of Hot Melt Extrusion
Kshitij Chitnis
Favorite
Chiu, Mark

Tavotek Biopharmaceutics
(M1030-10-65) Clinical Correlation of Conventional Allometric Scaling Approach for PK Predictions of FcRn Enhanced and Protease Resistant Long-Acting mAbs, TAVO101 and TAVO103
Mark Chiu
Favorite
(T1530-10-63) Prediction of Human PK for Multispecific Antibody TAVO412 Using Non-linear Population PK Model and Allometric Scaling
Mark Chiu
Favorite
Chivukula, Bhavana

Tergus Pharma, LLC
(T1230-01-04) Evaluation of Critical Quality Attributes (CQA’s) of Carbomer Based Topical Hydro Gels with Process Analytical Technique (PAT)
Bhavana Chivukula
Favorite
Chiyi, Xiong

MD Anderson Cancer Center
(M1030-04-24) Synthesis of Rhenium Tricarbonyl Phenformin Complex as an Anticancer Theragnostic Agent and Development of LC-MS/MS Assay for Pharmacokinetic Study
Xiong Chiyi
Favorite
Cho, Chang-Keun

SungKyunKwan University
(T1330-10-68) Effects of Clarithromycin on the Pharmacokinetics of Pitavastatin and Its Lactone Metabolite in Different SLCO1B1 Diplotypes
Chang-Keun Cho
Favorite
(W0930-10-68) Physiologically Based Pharmacokinetic (PBPK) Modeling to Predict the Pharmacokinetics of Pantoprazole According to CYP2C19 Genetic Polymorphism
Chang-Keun Cho
Favorite
(W1130-10-63) Physiologically Based Pharmacokinetic (PBPK) Modeling to Predict the Pharmacokinetics of Pitavastatin in Different SLCO1B1 Diplotypes
Chang-Keun Cho
Favorite
Cho, Hea-Young

CHA University
(M1030-10-66) Integrating Herbal Medicine into Modern Practice: Nonclinical Evaluation of Cinnamomum cassia Extract and Extrapolation from Animals to Humans
Hea-Young Cho
Favorite
(T1130-10-64) Explore Gender Differences in Perfluorooctanoic Acid Using Ontogeny Integrated Physiologically-Based Pharmacokinetic Model in Rats
Hea-Young Cho
Favorite
Cho, Hyunah

St. John's University
(T1430-08-49) 3D Printing of Single and Multi-unit Containers for Dispensing Solid Dosage Forms
Hyunah Cho
Favorite
Cho, Hyunmin

SungKyunKwan University
(T1230-05-31) Pharmacokinetics and Interspecies Scaling of Semaglutide, a GLP-1 Receptor Agonist
Hyunmin Cho
Favorite
(W1030-05-29) Pharmacokinetics of the Glucagon-Like Peptide-1 (GLP-1) Receptor Agonist Semaglutide in Rats
Hyunmin Cho
Favorite
Choi, Du Hyung

Daegu Catholic University
(M1030-12-80) Enhanced Ocular Delivery of lifitegrast Using New Contact Lens DDS System
Du Hyung Choi
Favorite
(M1330-12-80) Development of a Novel Therapeutic Contact Lens with the Embedded-Drug Chamber as an Ophthalmic Drug Delivery System for Dry Eye Syndrome
Du Hyung Choi
Favorite
(T1530-09-59) Development of the Quantitative Prediction Model by Applying Chemometric and Artificial Intelligence in the Near-Infrared Spectrum as Pharmaceutical Process Analytical Technology
Du Hyung Choi
Favorite
Choi, Garam

Etnova therapeutics Corp.
(T1030-10-67) Pharmacokinetic Characterization of ETN101, a Novel Anti-cancer Agent and Its Metabolites in Rats and Dogs
Garam Choi
Favorite
Choi, Go-Wun

CHA University
(M1030-10-66) Integrating Herbal Medicine into Modern Practice: Nonclinical Evaluation of Cinnamomum cassia Extract and Extrapolation from Animals to Humans
Go-Wun Choi
Favorite
(T1130-10-64) Explore Gender Differences in Perfluorooctanoic Acid Using Ontogeny Integrated Physiologically-Based Pharmacokinetic Model in Rats
Go-Wun Choi
Favorite
Choi, Heeyeon

Ministry of Food and Drug Safety
(T1130-09-60) A Study on the Modernization of Analytical Methods in Korean Pharmacopoeia
Heeyeon Choi
Favorite
Choi, Ho-Ik

Hanyang University
(M1430-12-82) Aceclofenac-Loaded Nanoparticulate Carriers with Enhanced Solubilization Using Deep Eutectic Solvents for Improved Transdermal Delivery
Ho-Ik Choi
Favorite
(T0930-12-78) Preparation and Evaluation of Dexamethasone Phosphate-Encapsulated Liposomal Gel Formulation for Intratympanic Delivery
Ho-Ik Choi
Favorite
Choi, Minji

Yonsei University
(M1430-03-17) Optimizing Microfluidic Process Parameters and Lipid-Cholesterol Composition for Lysozyme-Loaded Liposome Preparation
Minji Choi
Favorite
Choi, Monica

Mirati Therapeutics
(M1130-08-55) Effects of SDS Quality and Dissolution Medium Warm-Up Time on Dissolution Release of MRTX849 IR Tablets, 200 mg
Monica Choi
Favorite
Choi, Yu-Rim

Chungbuk National University
(M0930-03-18) Film-Coated Hard Capsules for Dry Powder Inhalers: Improving Inhalation Efficiency and In-Use Stability
Yu-Rim Choi
Favorite
(M1530-03-17) Improving Aerodynamic Performance with Spray-Dried Corrugated Chitosan Microparticles
Yu-Rim Choi
Favorite
Chong, Yae Eun

Rutgers University
(W1030-10-67) Pharmacokinetics of Biologics in Obese Rats
Yae Eun Chong
Favorite
Choonara, Yahya

University of Witwatersrand
(M1130-09-61) Biofouling Assessment of Zwitterionised Superhydrophilic Polyvinyl Alcohol Hydrogels using E. coli and S. aureus
Yahya Choonara
Favorite
Chopde, Pratiksha

Rashtrasant Tukadoji Maharaj Nagpur University
(W0930-11-74) Synergistic Effect of Bioenhancer for Increasing the Permeation of Lopinavir via Phospholipid Complexation
Pratiksha Chopde
Favorite
Chopski, Steven

US Food and Drug Administration
(T1030-10-66) Identifying Critical Parameters for Physiological Based Pharmacokinetic Modeling of Naloxone Hydrochloride Nasal Sprays
Steven Chopski
Favorite
(T1530-08-54) Critical Formulation Attributes of Naloxone Nasal Spray Products Affecting Nasal Permeation
Steven Chopski
Favorite
Chorianopoulou, Christina

National and Kapodistrian University of Athens
(T1130-11-72) Estimation of Drug Apparent Solubility in Gastric Contents after the Standard High-Calorie High-Fat Meal: Comparison of Data in Biorelevant Media with Data in Aspirates
Christina Chorianopoulou
Favorite
Cho, Seok-Jin

CHA University
(M1030-10-66) Integrating Herbal Medicine into Modern Practice: Nonclinical Evaluation of Cinnamomum cassia Extract and Extrapolation from Animals to Humans
Seok-Jin Cho
Favorite
(T1130-10-64) Explore Gender Differences in Perfluorooctanoic Acid Using Ontogeny Integrated Physiologically-Based Pharmacokinetic Model in Rats
Seok-Jin Cho
Favorite
Chougule, Mahavir

Mercer University
(M1230-12-80) Formulation Development and Characterization of Parenteral Nicardipine HCl Product for Intrathecal Administration
Mahavir Chougule
Favorite
(M1330-02-11) Formulation and Characterization of Non-invasive Nebulization Based Antiviral Drug, NSF207 Loaded Pegylated Nanoliposomal Suspension Product for Treatment of COVID-19
Mahavir Chougule
Favorite
(W1230-03-18) Stimuli-Responsive Newly Designed Poly (amino ether) Glycopolymer Based Pegylated Nanoparticles Conjugated with Receptor Binding Peptide for siRNA Delivery to Treat Lung Cancer
Mahavir Chougule
Favorite
Chou, Pochung

Rutgers - The State University of New Jersey
(T1430-10-67) Butyrate Drives Metabolic Rewiring and Epigenetic Reprogramming in Human Colon Cancer Cells
Pochung Chou
Favorite
Chou, Wei-Chun

University of Florida
(W1030-02-09) Development of an Artificial Intelligence-Based PBPK Model for Nanoparticles in Tumor-Bearing Mice
Wei-Chun Chou
Favorite
Chow, Shing Fung

University of Hong Kong
(M1230-11-75) Rational Development of Fingolimod-Curcumin Nanosuspension as a Potential Intranasal Neuroprotective Therapy after Ischemic Stroke
Shing Fung Chow
Favorite
Chow, Diana S-L

University of Houston
(W0930-04-28) Enhanced Cytotoxic Effect of Paclitaxel in Combination with Calcipotriol on Human Pancreatic Cancer Cells
Diana S-L Chow
Favorite
Chow, Diana S.-L.

University ot Houston
(M1030-04-24) Synthesis of Rhenium Tricarbonyl Phenformin Complex as an Anticancer Theragnostic Agent and Development of LC-MS/MS Assay for Pharmacokinetic Study
Diana S.-L. Chow
Favorite
(T1330-06-39) Pharmacokinetic and Pharmacodynamic Correlations of Riluzole and Etoricoxib in a Long-Evan Rat Model with Traumatic Brain Injury
Diana S.-L. Chow
Favorite
Chow, Keat Theng

Roquette Asia Pacific Pte. Ltd.
(T1530-09-58) Exploring Applications of Plant-Derived Polymers in Fused Deposition Modeling of Oral Pharmaceutical Tablets
Keat Theng Chow
Favorite
Christensen, Jakob

Gubra
(M1130-10-68) Influence of Bovine Serum Albumin on Colonic Mucus Permeation and Solubility of Celecoxib and Naproxen in Fasted State Simulated Colonic Fluids
Jakob Christensen
Favorite
Christfort, Juliane

University Cote d'Azur
(M0930-05-30) Dynamic In Vitro Cell Culture Model to Study Pathogenic Interactions in Periodontitis In Flow Using a Lab-on-a-Disc Platform
Juliane Christfort
Favorite
Chronowska, Maja

Fraunhofer Institute for Translational Medicine and Pharmacology
(M1430-08-49) An In Vitro Model for Acetaminophen Dissolution from Overdosed Oral Formulations
Maja Chronowska
Favorite
Chua, Nicholas

Roquette Asia Pacific Pte. Ltd.
(T1530-09-58) Exploring Applications of Plant-Derived Polymers in Fused Deposition Modeling of Oral Pharmaceutical Tablets
Nicholas Chua
Favorite
Chumakov, Volodymyr

Nitto Biopharma, Inc.
(W1030-09-57) Development, Qualification, and Application of an LC-CAD-MS Method for Determination of Lipid Content in an RNA-LNP Drug Product Containing Novel Lipids with Diverse Physiochemical Properties
Volodymyr Chumakov
Favorite
Chunduri, Tejasvi

Upkara, Inc
(T1530-08-49) Capillary Mediated Vitrification (CMV) is a User-Friendly Alternative to Lyophilization for the Production of Thermostable Bio-molecules
Tejasvi Chunduri
Favorite
Chung, Elisha

Regeneron
(W0930-01-03) Developing a Platform for Formulation Screening of High Concentration Monoclonal Antibodies (mAbs)
Elisha Chung
Favorite
(W0930-01-05) Assessment of Phenol and Benzyl Alcohol for Use as Preservatives in mAb Drug Therapies
Elisha Chung
Favorite
Chung, Hawook

Green Biopharma Corp.
(M1030-10-67) Determination of the Concentration of the Drug MG1113 in Human Sodium Citrate Plasma Using a Sandwich Electro Chemiluminescent Immunoassay (ECLIA)
Hawook Chung
Favorite
Chung, Hee Sun

US Food and Drug Administration
(M0930-10-67) Past-to-Present Comparison of Repeat Analysis-Related Observations in Pharmacokinetic Bioequivalence Studies Submitted in Abbreviated New Drug Applications
Hee Sun Chung
Favorite
Chung, Sooyeon

University of Mississippi
(T0930-03-17) Fabrication of Caffeine Transdermal Film Using the Hot-Melt Extrusion and Fused Deposition Modeling 3D Printing
Sooyeon Chung
Favorite
(W0930-11-71) Development of Multiple Structured Pulsatile Release Tablets via Hot Melt Extrusion and Dual-Nozzle Fused Deposition Modeling 3D Printing
Sooyeon Chung
Favorite
(W1130-11-70) Fabrication of Suppository Shells via Hot-Melt Extrusion Paired with Fused Deposition Modeling (FDM) 3D Printing Techniques
Sooyeon Chung
Favorite
Chure, Chetan

Contract Pharmaceuticals Ltd.
(M0930-08-50) Design, Development, and Evaluation of Novel Extended-Release Liposomal Topical Cream Formulation of Pregabalin Using Microemulsion Technique for the Treatment of Local Neuropathic Pain
Chetan Chure
Favorite
Chuvalo-Abraham, Jamie

Merck & Co., Inc.
(M1330-01-03) Formulation Testing of TiO2-Free Film Coating Alternatives from Three Film Coat Vendors
Jamie Chuvalo-Abraham
Favorite
Chu, Yanjie

Kashiv Biosciences
(M0930-09-57) Identification of Isomerization in IgG1 and Its Impact on Potency: Case Study of a Mab Biosimilar
Yanjie Chu
Favorite
Chvila, Stanislav

University of Chemistry and Technology Prague
(M1530-01-03) Drug Nanocrystals Enable Rapid Formulation Transfer from Liquid-Phase Pre-clinical Testing to First-in-Human Solid Dosage Forms
Stanislav Chvila
Favorite
Ciociola, Tecla

University of Parma
(M1230-02-11) Formulation and Biological Evaluation of Spray Dried Microparticles Loaded with LL37 Antimicrobial Peptide
Tecla Ciociola
Favorite
Cirilli, Micol

Universita degli Studi di Milano
(T1230-01-03) Novel Expandable Platform for Retentive Drug Delivery Systems
Micol Cirilli
Favorite
Civin, Curt

University of Maryland Baltimore
(W1130-01-04) Biodegradable Nanogels for Controlled Release of Artemisinin-Derived Drug to Treat Leukemia
Curt Civin
Favorite
Clark, Andrew

DigiM Solution LLC
(M1330-08-55) Understanding Release Mechanism and Development of Accelerated Release Tests for Long-Term Intrauterine Systems
Andrew Clark
Favorite
(T1530-11-73) Investigating the Relationship between Microstructural Properties and In Vitro Release Characteristics of PLGA Microspheres
Andrew Clark
Favorite
Clarke, Fiona

Pfizer Inc.
(W1030-12-82) Navigating Titanium Dioxide Free Coating Systems: Evaluating the Risk and Understanding the Alternatives
Fiona Clarke
Favorite
Clarke, James

Simcyp Limited
(T1230-11-70) Application of Physiologically Based Pharmacokinetic Modeling to the Prediction of In Vitro and In Vivo Permeation of the UV Filter Octocrylene
James Clarke
Favorite
Clarke, Samuel

Precision NanoSystems, Inc.
(M1230-03-17) Strategies for Producing Clinical and Commercial RNA-LNP Drug Products
Samuel Clarke
Favorite
(T1030-03-17) Optimized and Scalable LNP Composition for RNA Vaccine Delivery
Samuel Clarke
Favorite
Clay, Charlotte

Quotient Sciences
(T1430-11-71) Development of Hydrogel Polymer-Based Bilayer Gastro-Retentive Modified-Release Tablets
Charlotte Clay
Favorite
Clegg, Benjamin

Duquesne University
(M1030-11-72) Guided Assembly of Lymph Node Stromal Cells Using a Biomaterial Formulation
Benjamin Clegg
Favorite
Coble, Kelly

BIPI
(M1230-06-36) Method Development and Validation of a Sensitive and Robust Human Serum PK Immunoassay for a Novel Bispecific Antibody by an Automated Microfluidic System
Kelly Coble
Favorite
(T1130-06-36) Method Development of BI-X ADC Gyrolab Assay for the Determination of Anti-BI-X Antibodies
Kelly Coble
Favorite
Coelho, Sergio

US Food and Drug Administration
(T1230-08-55) Long-Term Stability of In-House Sunscreen Formulations
Sergio Coelho
Favorite
Coghlan, Philip

Nyrada Inc
(T1130-03-21) Use of High-Pressure Homogenization to Prepare a Nano-suspension for Intravenous Administration
Philip Coghlan
Favorite
Cohen, Rachel

Meso Scale Discovery
(M1230-06-37) Development of a Sensitive and Specific Phospho-Tau 217 [Tau (pT217)] Biomarker Assay for Alzheimer’s Disease in Plasma and Serum
Rachel Cohen
Favorite
Coles, Lisa

University of Minnesota
(T1430-10-66) Pharmacokinetics of Nervonic Acid, a Monounsaturated Fatty, in an Adrenoleukodystrophy (ALD) Mouse Model
Lisa Coles
Favorite
Colman Segura, Otilia

PTC Therapeutics, Inc.
(W1130-10-68) Development of Stable Flocculated Suspension Formulation for Preclinical Studies
Otilia Colman Segura
Favorite
Colston, Kyle

Purdue University
(M0930-03-16) New Insight into the Oral Delivery Mechanism of Semaglutide Based on All-atom Molecular Dynamics Simulations
Kyle Colston
Favorite
Comisso, Davide

Aptuit (Verona) Srl, an Evotec Company
(M0930-11-71) Characterization of Compression Behavior of Co-processed Excipient for Production of Orally Dispersible Tablets and of Their Blends with Active Ingredient
Davide Comisso
Favorite
(M1130-11-70) A DoE Approach to Study the Influence of TSWG Process Parameters on the Characteristics of Granules and Tablets
Davide Comisso
Favorite
Cone, Roger

University of Michigan
(T0930-03-16) Remote Loading of Setmelanotide in Poly(lactic-co-glycolic acid) Microspheres for Long-Term Obesity Control
Roger Cone
Favorite
Connaughton, Patrick

AstraZeneca
(M1530-03-16) Robust Rugose Lipid Microparticles for Respiratory Delivery of Biologics
Patrick Connaughton
Favorite
Connolly, James

Applied Materials
(M1330-03-15) Effect of Atomic Layer Coatings on the Stability of Solid Myoglobin Formulations
James Connolly
Favorite
Connor, Amanda

Alcami Corporation
(M1530-09-62) Quantitation of Ethylene Oxide and Nitrosamines in Excipients and Pharmaceutical Products Using SIFT-MS
Amanda Connor
Favorite
Contrella, Nathan

Merck & Co., Inc.
(W1130-09-57) Re-Development of a Fit-for-Purpose Assay Degradation HPLC Method Using Open Lab Software
Nathan Contrella
Favorite
Conway, Sandra

Pfizer Inc.
(W1030-12-82) Navigating Titanium Dioxide Free Coating Systems: Evaluating the Risk and Understanding the Alternatives
Sandra Conway
Favorite
Cookson, Colt

Veloxity Labs, LLC
(M1030-06-38) Immunocapture LC-MS/MS Assay for the Biomarker, Troponin Fast (TNNI2) Using a Specific Antibody
Colt Cookson
Favorite
Cooley, Megan

ICON Plc
(W1030-06-38) Use of Human Plasma as a Surrogate Matrix for Quantitation of Modified Protein Therapy across Multiple Tumor Tissues
Megan Cooley
Favorite
Cooper, Brandon

University of Maryland Baltimore
(W1130-01-04) Biodegradable Nanogels for Controlled Release of Artemisinin-Derived Drug to Treat Leukemia
Brandon Cooper
Favorite
Cooper, Brett

Pharmaron UK Ltd
(T1430-12-81) Novel High Throughput Polymer Screening for Development of Amorphous Solid Dispersion
Brett Cooper
Favorite
Cooper, Vance

Patheon, part of Thermo Fisher Scientific
(M0930-05-33) Development of a Water-Soluble Mini-Tablet Formulation for Flow Cytometry Applications
Vance Cooper
Favorite
Cooreman, Caroline

International Flavors and Fragrances Inc.
(W0930-11-73) Oral Tablets Containing a Model Protein API – Impacts of Excipient Selection, API Loading, Unit Operation, and Manufacturing Process Parameters on Tablet Properties, Performance, and Stability
Caroline Cooreman
Favorite
Copik, Alicja J.

University of Central Florida
(M1230-04-26) Flow Cytometry and Confocal Microscopy to Quantify β-lactam Penetration in a Double β-lactamase and Double Efflux Pump Knockout Strain of Acinetobacter baumannii (AB)
Alicja J. Copik
Favorite
Corbin, Ian

University of Texas Southwestern Medical Center
(T1330-06-38) Rapid Quantitation of Docosahexaenoic Acid and Its Hydroxy Metabolites in Liver Cells Using Differential Mobility Separation (SelexION) Coupled with Liquid Chromatography Tandem Mass Spectrometry
Ian Corbin
Favorite
Cordero, Marjorie

Adare Pharma Solutions
(T1430-03-20) The Impact of Particle Size of the Drug Substance on Dissolution of Finished Product for the Treatment of Cushing’s Disease in Dogs
Marjorie Cordero
Favorite
Coss, Chris

Ohio State University
(M1530-05-29) The Effect of Cancer-Associated Cachexia on the Pharmacokinetics of Extra-vascularly Administered Monoclonal Antibodies
Chris Coss
Favorite
Costa, Antonio

University of Connecticut
(T1330-08-49) Continuous Processing of Liposomal Nanoparticles as Potential Reference Materials for Drug Product Development
Antonio Costa
Favorite
Costa, Jose

UNICAMP
(M1130-04-28) Could the Plasmatic miRNAs hsa-miR-4433b-5p, hsa-miR-320b and hsa-miR-16-2-2p Be Biomarkers of Covid-19?
Jose Costa
Favorite
(T1130-04-24) Downregulated Expression Levels of miR-451a and miR-185-5p as Potential Biomarkers for Coronavirus Disease 2019 (COVID-19) Severity
Jose Costa
Favorite
Costales, Chester

Pfizer Inc.
(M1230-05-31) Impact of Pre-incubation on BCRP and P-gp Transporter Inhibition in the Membrane Vesicle Assay
Chester Costales
Favorite
Costanzo, Margaret

Amador Bioscience
(T1530-06-39) A Two-Part Method for the Separation and Quantification of Free and Encapsulated ASOs by Hybridization ELISA
Margaret Costanzo
Favorite
Costa, Sílvia

Instituto Superior Tecnico de Lisboa
(T1430-03-15) Beyond Conventional Boundaries: New Excipients for ASD Formulation
Sílvia Costa
Favorite
Costello, Cormac

National Institute for Bioprocessing Research
(M1330-03-15) Effect of Atomic Layer Coatings on the Stability of Solid Myoglobin Formulations
Cormac Costello
Favorite
Costello, Mark

University of Texas at Austin
(T0930-11-75) Role of PLGA Variability in Controlled Drug Release from Dexamethasone Intravitreal Implants
Mark Costello
Favorite
Cote, Simon

West Pharmaceutical Services Inc.
(W1030-02-10) Evolving Component Technologies to Meet the Needs of Large Volume Injections
Simon Cote
Favorite
Couchman, Lewis

Kings College London
(T1430-05-30) The Use of Short 10 mm Columns for Ultra-fast LC-MS Analyses
Lewis Couchman
Favorite
Coulter, Donald

University of Nebraska Medical Center
(W1230-10-64) COG133-Targeted Polymeric Nanoparticles Encapsulating PLK-1 Inhibitor Blocks DNA-Damage Repair Pathways to Sensitize Medulloblastoma Cells for Radiotherapy
Donald Coulter
Favorite
Coutinho, Ana

University of Maryland Baltimore
(M1130-05-30) A Robust, Viable, and Resource Sparing HPLC-Based logP Method Applied to Common Drugs
Ana Coutinho
Favorite
Cowans, Brett

Improved Pharma
(M1230-08-49) Physical Evaluation of a Late Appearing Polymorph of Ritonavir Form III
Brett Cowans
Favorite
Coyle, Norman

Colorcon, Inc.
(M1230-03-19) Preparation of Osmotic Tablets Using a Direct-to-Hopper Formulated Push Layer Based on Polyethylene Oxide
Norman Coyle
Favorite
Coyne, Jacob

Altis Biosystems
(T0930-10-67) A Sensitive and Specific Human Primary Stem Cell-Based In Vitro Assay for Predicting Gastrointestinal Toxicity Risk
Jacob Coyne
Favorite
Crawford, Mitch

Freund-Vector Corporation
(T1030-09-58) Comparing the Performance of Wet and Dry Polymer Binders in High Shear Wet Granulation and Twin-Screw Granulation Processes
Mitch Crawford
Favorite
Crean, Abina

University College Cork
(M1130-09-57) Revisiting UV Spectroscopy for Real-Time Monitoring of Reversible Protein Unfolding
Abina Crean
Favorite
Cristini, Vittorio

Houston Methodist Research Institute
(W1130-10-66) Multiscale Modeling-Identified Synergistic Combinations of Anti-microRNA-155 and Standard-of-Care Drugs for Improved Outcomes in Non-small Cell Lung Cancer
Vittorio Cristini
Favorite
Cristofoletti, Rodrigo

University of Florida
(M0930-10-69) Mechanistic Modeling of In Vitro Biopharmaceutic Experiments for a Weakly Dibasic Drug for Incorporation into PBPK Models
Rodrigo Cristofoletti
Favorite
(M0930-11-70) A Comparative Study of In Vitro Itraconazole Drug Release from Amorphous Solid Dispersions (ASDs): Sempera® and Tolsura® under Fed State Conditions
Rodrigo Cristofoletti
Favorite
(M1130-05-30) A Robust, Viable, and Resource Sparing HPLC-Based logP Method Applied to Common Drugs
Rodrigo Cristofoletti
Favorite
(M1230-10-64) PBPK Modeling Coupled with Biorelevant Dissolution to Forecast the Oral Performance of Amorphous Solid Dispersion Formulations
Rodrigo Cristofoletti
Favorite
(M1530-10-68) Assessing the In Vitro Performance of Solid Dosage Forms Over-Encapsulated with the ID-Cap System for Improved Compliance
Rodrigo Cristofoletti
Favorite
(T0930-10-69) Optimizing Carvedilol Dosing Following Gastric Bypass Surgery Using Population-Based PK/PD Modeling
Rodrigo Cristofoletti
Favorite
Cristovao, Joana

Hovione PharmaScience SA
(M1530-12-78) Hot and Cold Formulation of Biologics for the Optimization of Drying Technologies
Joana Cristovao
Favorite
(T1230-12-77) Analytical Characterization for Nucleic Acid Therapy: A Case Study
Joana Cristovao
Favorite
Crooks, Jason

GlaxoSmithKline plc
(M1230-09-61) Predicting Granule and Tablet Properties Using In-Line Measurements and Evolutionary Equation Discovery
Jason Crooks
Favorite
Croquet, Sebastien

Roquette Freres
(T1130-03-20) Fast Tablet Hard Coating with Xylitol
Sebastien Croquet
Favorite
Crowe, Alexandra

Certera
(T1130-05-32) Global Identification of OATP1B1-Associated Proteins and Implications of Calcineurin Inhibition in Time-Dependent OATP1B1 Inhibition
Alexandra Crowe
Favorite
Croyle, Maria

University of Texas at Austin
(T0930-04-23) Impact of a Novel Thin Film Platform on the Uptake and Permeability of Virus-Based Vaccines in an In Vitro Model of the Human Oral Mucosa
Maria Croyle
Favorite
Cruz, Erlen

Instituto de Investigaciones Biológicas Clemente Estable
(M1230-12-81) Ciprofloxacin-Loaded Albumin Nanoparticles as a New Strategy for the Treatment of Urinary Tract Infections and Catheter-Associated Urinary Tract Infections
Erlen Cruz
Favorite
Cruz, Kerry

Natoli Scientific
(T1030-03-20) Material Deformation or Material Hardness or Both: Tool for Predicting Tabletability Performance
Kerry Cruz
Favorite
Cuevas, Juan Cruz

Probius Inc
(M1530-10-63) Quantum Electrochemical Spectroscopy (QES): A Novel Approach for Enhanced Detection and Evaluation of Drug-Induced Liver Injury (DILI)
Juan Cruz Cuevas
Favorite
(T1430-06-37) Quantum Electrochemical Spectroscopy (QES): A Novel AI-Driven Spectroscopic Approach to Simplify Bioanalytical Development in the Pharmaceutical and Biotech Industries
Juan Cruz Cuevas
Favorite
Cui, Di

US Food and Drug Administration
(M1230-05-30) Application of Quantitative Models to Systematically Evaluate Factors Impacting Swallowability of Tablets
Di Cui
Favorite
Cui, Haixi

University of Maryland Baltimore
(T1030-03-15) Expanding the Space of Hydroxyl-Rich Lyoprotectants through High-Throughput Screening to Support the Lyophilization of Yeast-Based Therapeutics
Haixi Cui
Favorite
Cui, Qian

WuXi AppTec (Shanghai) Co., Ltd.
(M1330-06-40) A Comprehensive Bioanalytical Strategy of In Vivo Studies for RNAi Therapeutics in Early Discovery
Qian Cui
Favorite
Cui, Shuquan

University of Minnesota
(M1430-11-74) Mechanism of Stabilization of Amorphous Solid Dispersion above the Overlap Concentration (c*): Delay of the First Nucleation Event
Shuquan Cui
Favorite
Cui, Yanyan

Stoke Therapeutics, Inc.
(M1130-06-40) Development and Validation of a Sensitive Hybridization-Electrochemiluminescence (H-ECL) Method for Quantitation of STK-002, an Antisense Oligonucleotide, in Human Serum
Yanyan Cui
Favorite
Cui, Yusi

Genentech, Inc.
(T0930-06-40) Optimizing Discovery Bioanalytical Strategy for Macrocyclic Peptides and Degraders with Orbitrap High Resolution Mass Spectrometry
Yusi Cui
Favorite
Cui, Zhengrong

University of Texas at Austin
(M1130-01-05) Toward Enhanced Stability of mRNA Lipid Nanoparticles
Zhengrong Cui
Favorite
(M1430-03-15) Development of 3D Printable Inks for Protein Delivery
Zhengrong Cui
Favorite
(T1330-03-15) Viable Eukaryotic Cell Dry Powders Prepared by Thin Film Freeze-Drying
Zhengrong Cui
Favorite
(W0930-03-15) Oral Delivery of Probiotics Using Delayed-Release Capsules: Formulation and Dosage Form Considerations
Zhengrong Cui
Favorite
Cunha Filho, Marcilio

University of Brasilia
(T1230-03-17) FDM 3D Printing Tablets Containing Iron Oxide Nanoparticles to Treat Iron Deficiency
Marcilio Cunha Filho
Favorite
(T1430-12-82) Personalized 3D Printing Earring Tap for Treating Affections Caused by Aesthetic Perforations
Marcilio Cunha Filho
Favorite
Curran, Geoffry

Mayo Clinic
(T1130-05-33) High-Density Lipoprotein Mimetic Peptide 4F Reduces Amyloid Beta Peptide Accumulation in the Blood-Brain Barrier Endothelium of Alzheimer’s disease brain
Geoffry Curran
Favorite
Cursino, Maria

UNICAMP
(M0930-04-28) Associations of Polymorphisms of the ABCB1 and ABCC2 Genes with Cisplatin-Induced Nephrotoxicity and Myelosuppression in Patients with Head and Neck Cancer
Maria Cursino
Favorite
(M1330-04-26) Urinary MicroRNAs as Possible Biomarkers of Cisplatin-Induced Nephrotoxicity in Patients with Head and Neck Cancer
Maria Cursino
Favorite
Cusin, Lucas

Evonik Nutrition & Care GmbH
(M1130-03-16) Enteric Functional Ready-to-Fill Capsule Solution from Pre-Clinic to Commercial
Lucas Cusin
Favorite
Cychosz Struckoff, Katie

Anton Paar USA, Inc.
(T1130-08-49) Excipient Characterization: Solid Density and Surface Area
Katie Cychosz Struckoff
Favorite
Czernik-Schulz, Dominika

SE Tylose GmbH & Co. KG
(T1330-03-17) Development of Hydroxypropyl Methylcellulose (HPMC)-Based, Titanium Dioxide (TiO₂)-Free Coating
Dominika Czernik-Schulz
Favorite